Optellum

What is Optellum?

Optellum is a lung health company that makes AI tools for early lung cancer diagnosis. Its main product, the Virtual Nodule Clinic (VNC), finds, tracks and assesses malignancy risk for patients with lung nodules. The vendor describes its Lung Cancer Prediction AI as FDA-cleared and UKCA and CE marked.

Key capabilities of Optellum

• Virtual Nodule Clinic: Finds, tracks and manages patients with lung nodules.
• Lung Cancer Prediction AI: A radiomics model that estimates malignancy risk of a nodule.
• Patient Discovery AI: Identifies patients with nodules who need follow-up.
• Triage, tracking and management: Workflow tools for routing and following up on nodule patients.
• EHR and PACS integration: Connects to hospital imaging and records systems.
• Rapid Enterprise deployment: Deployable through RapidAI's Rapid Enterprise platform with a single IT deployment.

How Optellum works

Optellum analyzes chest CT scans to locate nodules, scores their malignancy risk with the prediction model, and surfaces patients who need follow-up. Care teams manage those patients through triage and tracking workflows linked to the EHR and PACS, so clinicians see risk and next steps in their usual systems.

Who uses Optellum?

Providers such as health systems and thoracic care teams use Optellum, and life-science companies are listed as partners. Imaging provider SimonMed uses the prediction AI for incidental lung nodules, according to the vendor. It is a clinical product, not a consumer tool, and results should be reviewed by clinicians.

Optellum pricing

Optellum does not publish pricing. The site directs visitors to contact the company or book a demo, so pricing is quote-based.

Optellum alternatives

Qynapse applies AI to neuro imaging, so it addresses brain rather than lung disease. Navina is an AI assistant that summarizes patient records for primary care clinicians. Harrison.ai offers radiology AI solutions across several imaging tasks, including chest X-ray.